Company News

Sinclair Research appoints Scott Boley as VP of Toxicology OptiBiotix appoints new Director of Research and Development Almac Group expands executive team The global CDMO has announced the appointment of three new Vice Presidents within its Pharma Services Business Unit MedPharm strengthens its board with new members Sir Paul Nurse receives honorary doctorate and offers words of wisdom to graduates The Nobel Prize winner told an audience of new graduates of the University of Huddersfield how science was of particular importance in today's world because it has the power to... CNH names news chairman Owlstone Medical appoints five experts to Scientific Advisory Board The additions form a key strategic resource to advise on Breath Biopsy platform, product and study development Ardmac appoints Head of Engineering Rentschler Fill Solutions names General Manager Operations Dr Margit Klotz to oversee Process Development & Manufacturing, Quality and Engineering, effective 1 August 2018 BONESUPPORT appoints Michael Diefenbeck as Head of R&D, Medical and Clinical Affairs Walmart EVP and Amgen SVP join rfxcel’s Board of Directors New CEO at Silence Therapeutics Telesales Executive (Digital Media, Cosmetics & Pharma) HPCi Media – London, UK Steve Yemm appointed CEO of BioData BioData has announced the appointment of Steve Yemm as CEO, following a decade of growth in the adoption of its flagship product Labguru Leading Alzheimer's Disease scientist joins NeuroCog Trials Marlene Leuenberger joins Catalent

Trending Articles

  1. Alfa Laval appoints new managing director to drive strategic growth Alessandro Bracco will lead Alfa Laval UK & Ireland as the company targets growth opportunities across key sectors, including pharmaceutical
  2. How strong leadership transforms regulatory and operational challenges Why SLTs fail on the PQS/QMS: The leadership gap undermining quality
  3. Entact Bio appoints John G. Houston, Ph.D., to its Board of Directors A veteran biopharma innovator who helped advance the first FDA-approved PROTAC drug, Dr. Houston will strengthen Entact's leadership in induced-proximity therapeutics
  4. Kindeva appoints Brok Weichbrodt as Chief Transformation Officer to accelerate growth strategy and commercial excellence Kindeva, a global drug delivery Contract Development and Manufacturing Organization (CDMO), today announced the appointment of Brok Weichbrodt as Chief Transformation Officer to strengthen operational excellence, scale execution, and accelerate growth as the company enters the next phase of its value creation plan
  5. Medicines Discovery Catapult selects prominent UK life sciences leader, Professor Sir Mike Ferguson, as its incoming Chair of the Board MDC welcomes new Chair from January 2027 to drive impact as next-generation technologies and collaborations reshape drug discovery

Upcoming event

CPhI Milan

6–8 October 2026 | Exhibition | Fiera Milano, Italy See all